Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 0.71% is 97% below its 2-year average of 21.55%, near the low end of its 2-year range (0.71%–205.42%).
As of the fiscal period ended Tuesday, June 30, 2026. 58.80% below its 12-month average of 1.73%.
Reported quarterly debt to assets ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 0.71%.
DEBT TO ASSETS RATIO
0.71%
DEBT TO ASSETS RATIO AVG TTM
1.73%
DEBT TO ASSETS RATIO AVG 3Y
N/A
DEBT TO ASSETS RATIO AVG 5Y
N/A
DEBT TO ASSETS RATIO AVG 10Y
N/A
DEBT TO ASSETS RATIO AVG 15Y
N/A
DEBT TO ASSETS RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-58.80%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.11%
median of 465 covered companies
CURRENT VS SECTOR MEDIAN
+549.30%
vs the sector median at left
BioAge Labs Inc.
Market Cap
$239.45M
Debt to Assets Ratio
0.71%
TTM Avg
1.73%
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$244.25M
Debt to Assets Ratio
0.15%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$245.65M
Debt to Assets Ratio
9.29%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$248.21M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$251.64M
Debt to Assets Ratio
0.03%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| BioAge Labs Inc. (BIOA) | $239.45M | 0.71% | 1.73% | N/A | N/A |
| High Tide Inc. (HITI)vs › | $239.89M | 0.33% | N/A | N/A | N/A |
| Biodesix, Inc. (BDSX)vs › | $236.56M | 0.75% | N/A | N/A | N/A |
| Akebia Therapeutics, Inc. (AKBA)vs › | $244.25M | 0.15% | N/A | N/A | N/A |
| Galectin Therapeutics Inc. (GALT)vs › | $245.65M | 9.29% | N/A | N/A | N/A |
| InflaRx N.V. (IFRX)vs › | $247.45M | 0.00% | N/A | N/A | N/A |
| Greenwich LifeSciences, Inc. (GLSI)vs › | $248.21M | 0.00% | N/A | N/A | N/A |
| CAMP4 Therapeutics Corporation (CAMP)vs › | $251.64M | 0.03% | N/A | N/A | N/A |
| Alector, Inc. (ALEC)vs › | $220.94M | 0.16% | N/A | N/A | N/A |
| Eupraxia Pharmaceuticals Inc. (EPRX)vs › | $259.30M | 0.01% | N/A | N/A | N/A |
Debt/Assets
0.7%
Debt/Equity
0.01
Current Ratio
17.19
Interest Coverage
-133.1x
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 0.71% |
| 2026-03-31 | 1.01% |
| 2025-12-31 | 1.89% |
| 2025-09-30 | 2.34% |
| 2025-06-30 | 2.71% |
| 2025-03-31 | 3.00% |
| 2024-12-31 | 2.43% |
| 2024-09-30 | 3.03% |
| 2024-06-30 | 7.12% |
| 2024-03-31 | 7.35% |
| 2023-12-31 | 205.42% |
